Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations - PubMed (original) (raw)

Comparative Study

Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations

S L Moghazeh et al. Antimicrob Agents Chemother. 1996 Nov.

Abstract

A collection of 24 rifampin-resistant clinical isolates of Mycobacterium tuberculosis with characterized RNA polymerase beta-subunit (rpoB) gene mutations was tested against the antimycobacterial agents rifampin, rifapentine, and KRM-1648 to correlate levels of resistance with specific rpoB genotypes. The results indicate that KRM-1648 is more active in vitro than rifampin and rifapentine, and its ability to overcome rifampin resistance in strains with four different genetic alterations may prove to be useful in understanding structure-function relationships.

PubMed Disclaimer

Similar articles

• Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
  Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, Maesaki S, Tomono K, Tashiro T, Kohno S. Yang B, et al. J Antimicrob Chemother. 1998 Nov;42(5):621-8. doi: 10.1093/jac/42.5.621. J Antimicrob Chemother. 1998. PMID: 9848446
• Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis.
  Williams DL, Spring L, Collins L, Miller LP, Heifets LB, Gangadharam PR, Gillis TP. Williams DL, et al. Antimicrob Agents Chemother. 1998 Jul;42(7):1853-7. doi: 10.1128/AAC.42.7.1853. Antimicrob Agents Chemother. 1998. PMID: 9661035 Free PMC article.
• Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis.
  Park YK, Kim BJ, Ryu S, Kook YH, Choe YK, Bai GH, Kim SJ. Park YK, et al. Int J Tuberc Lung Dis. 2002 Feb;6(2):166-70. Int J Tuberc Lung Dis. 2002. PMID: 11931418
• Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
  Zaw MT, Emran NA, Lin Z. Zaw MT, et al. J Infect Public Health. 2018 Sep-Oct;11(5):605-610. doi: 10.1016/j.jiph.2018.04.005. Epub 2018 Apr 26. J Infect Public Health. 2018. PMID: 29706316 Review.
• Prospects for development of new antimycobacterial drugs.
  Tomioka H. Tomioka H. J Infect Chemother. 2000 Mar;6(1):8-20. doi: 10.1007/s101560050043. J Infect Chemother. 2000. PMID: 11810525 Review.

Cited by

• Few amino acid positions in rpoB are associated with most of the rifampin resistance in Mycobacterium tuberculosis.
  Cummings MP, Segal MR. Cummings MP, et al. BMC Bioinformatics. 2004 Sep 28;5:137. doi: 10.1186/1471-2105-5-137. BMC Bioinformatics. 2004. PMID: 15453919 Free PMC article.
• Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples.
  Gamboa F, Cardona PJ, Manterola JM, Lonca J, Matas L, Padilla E, Manzano JR, Ausina V. Gamboa F, et al. Eur J Clin Microbiol Infect Dis. 1998 Mar;17(3):189-92. doi: 10.1007/BF01691116. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9665301
• Rapid Microarray-Based Detection of Rifampin, Isoniazid, and Fluoroquinolone Resistance in Mycobacterium tuberculosis by Use of a Single Cartridge.
  Havlicek J, Dachsel B, Slickers P, Andres S, Beckert P, Feuerriegel S, Niemann S, Merker M, Labugger I. Havlicek J, et al. J Clin Microbiol. 2018 Jan 24;56(2):e01249-17. doi: 10.1128/JCM.01249-17. Print 2018 Feb. J Clin Microbiol. 2018. PMID: 29212699 Free PMC article.
• Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies.
  Prasad R. Prasad R. Lung India. 2012 Apr;29(2):154-9. doi: 10.4103/0970-2113.95321. Lung India. 2012. PMID: 22628931 Free PMC article.
• In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureus.
  Murphy CK, Mullin S, Osburne MS, van Duzer J, Siedlecki J, Yu X, Kerstein K, Cynamon M, Rothstein DM. Murphy CK, et al. Antimicrob Agents Chemother. 2006 Mar;50(3):827-34. doi: 10.1128/AAC.50.3.827-834.2006. Antimicrob Agents Chemother. 2006. PMID: 16495239 Free PMC article.

References

1. 1. N Engl J Med. 1996 Jun 13;334(24):1573-6 - PubMed
2. 1. Am J Respir Crit Care Med. 1996 Feb;153(2):837-40 - PubMed
3. 1. Antimicrob Agents Chemother. 1996 Feb;40(2):298-301 - PubMed
4. 1. Antimicrob Agents Chemother. 1996 Feb;40(2):426-8 - PubMed
5. 1. Chem Pharm Bull (Tokyo). 1993 Jan;41(1):148-55 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database